# IMWG myeloma response

IMWG response

Status: LIVE
Price: $0.005 USDC
`GET /api/calc/imwg_response`
HTML: https://magentlab.com/docs/imwg-response
Markdown: https://magentlab.com/docs/imwg-response.md

Not a medical device. Not a diagnosis, dose, or listing recommendation.

## What it computes

Apply Kumar 2016 International Myeloma Working Group consensus criteria for treatment response in multiple myeloma on the measurable serum and urine M-protein pathway, returning sCR, CR, VGPR, PR, MR, SD, or PD from caller-assigned flags.

## When to use

When an agent already has caller-assigned IMWG 2016 response flags for a patient with measurable serum and urine M-protein and needs the published first-match category. magent does not assay M-protein or free light chains, does not read marrow, and does not compute PD from serial values.

## When not to use

- Not a medical device.
- Not a diagnosis. Response category is not a myeloma diagnosis or a treatment recommendation.
- Not the Rajkumar 2014 IMWG definition of multiple myeloma requiring therapy (imwg-myeloma).
- Measurable serum and urine M-protein pathway only. FLC-only and nonsecretory alternate PR pathways are not scored.
- Flow or NGS MRD-negativity categories are not scored.
- magent does not assay M-protein, free light chains, or immunofixation, and does not read marrow or immunohistochemistry. All flags are caller-assigned.
- imwg_pd is progressive disease as assigned by the caller using IMWG PD rules. magent does not compute PD from serial M-protein, FLC, or imaging values.
- bmpc_lt_5 is strictly fewer than 5% plasma cells in bone marrow aspirates (Kumar 2016 CR), not ≤5%.

## Formula

```
Kumar 2016 IMWG measurable serum+urine M-protein response, first-match: PD if imwg_pd; else sCR iff CR_bits and flc_ratio_normal and no_clonal_cells_ihc; else CR iff CR_bits; else VGPR iff electrophoresis_negative or (serum_m_reduction_ge_90 and urine_m_lt_100); else PR iff serum_m_reduction_ge_50 and urine_m_pr; else MR iff serum_m_reduction_25_to_49 and urine_m_reduction_50_to_89; else SD. CR_bits = ife_serum_negative and ife_urine_negative and plasmacytomas_absent and bmpc_lt_5 (strictly <5% marrow plasma cells). Not FLC-only or nonsecretory. Not MRD. Not a diagnosis
```

## Citation

[International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma](https://doi.org/10.1016/S1470-2045(16)30206-6)
Kumar S, Paiva B, Anderson KC, Durie B, Landgren O, Moreau P, Munshi N, Lonial S, Bladé J, Mateos MV, Dimopoulos M, Kastritis E, Boccadoro M, Orlowski R, Zamagni E, Palumbo A, San Miguel J, Avet-Loiseau H, Goldschmidt H, van de Donk NWCJ, et al.
Lancet Oncol. 2016;17(8):e328-e346
DOI: [10.1016/S1470-2045(16)30206-6](https://doi.org/10.1016/S1470-2045(16)30206-6)

## Worked example

### Stringent complete response

Given: `bmpc_lt_5=true, electrophoresis_negative=false, flc_ratio_normal=true, ife_serum_negative=true, ife_urine_negative=true, imwg_pd=false, no_clonal_cells_ihc=true, plasmacytomas_absent=true, serum_m_reduction_25_to_49=false, serum_m_reduction_ge_50=false, serum_m_reduction_ge_90=false, urine_m_lt_100=false, urine_m_pr=false, urine_m_reduction_50_to_89=false`

1. imwg_pd false
2. ife_serum_negative, ife_urine_negative, plasmacytomas_absent, and bmpc_lt_5 true → CR_bits true
3. flc_ratio_normal true and no_clonal_cells_ihc true → sCR


### Complete response without sCR extras

Given: `bmpc_lt_5=true, electrophoresis_negative=false, flc_ratio_normal=false, ife_serum_negative=true, ife_urine_negative=true, imwg_pd=false, no_clonal_cells_ihc=true, plasmacytomas_absent=true, serum_m_reduction_25_to_49=false, serum_m_reduction_ge_50=false, serum_m_reduction_ge_90=false, urine_m_lt_100=false, urine_m_pr=false, urine_m_reduction_50_to_89=false`

1. imwg_pd false; CR_bits true
2. flc_ratio_normal false; no_clonal_cells_ihc true
3. CR (sCR requires both a normal FLC ratio and no clonal cells by IHC)


### VGPR by electrophoresis-negative M-protein

Given: `bmpc_lt_5=false, electrophoresis_negative=true, flc_ratio_normal=false, ife_serum_negative=false, ife_urine_negative=false, imwg_pd=false, no_clonal_cells_ihc=false, plasmacytomas_absent=false, serum_m_reduction_25_to_49=false, serum_m_reduction_ge_50=false, serum_m_reduction_ge_90=false, urine_m_lt_100=false, urine_m_pr=false, urine_m_reduction_50_to_89=false`

1. imwg_pd false; CR_bits false
2. electrophoresis_negative true (IFE-detectable M-protein not seen on electrophoresis)
3. VGPR


### Partial response

Given: `bmpc_lt_5=false, electrophoresis_negative=false, flc_ratio_normal=false, ife_serum_negative=false, ife_urine_negative=false, imwg_pd=false, no_clonal_cells_ihc=false, plasmacytomas_absent=false, serum_m_reduction_25_to_49=false, serum_m_reduction_ge_50=true, serum_m_reduction_ge_90=false, urine_m_lt_100=false, urine_m_pr=true, urine_m_reduction_50_to_89=false`

1. imwg_pd false; CR_bits false; electrophoresis_negative false
2. serum_m_reduction_ge_90 false so the VGPR M-protein clause is not met
3. serum_m_reduction_ge_50 true and urine_m_pr true → PR


### Progressive disease as assigned by the caller

Given: `bmpc_lt_5=false, electrophoresis_negative=false, flc_ratio_normal=false, ife_serum_negative=false, ife_urine_negative=false, imwg_pd=true, no_clonal_cells_ihc=false, plasmacytomas_absent=false, serum_m_reduction_25_to_49=false, serum_m_reduction_ge_50=false, serum_m_reduction_ge_90=false, urine_m_lt_100=false, urine_m_pr=false, urine_m_reduction_50_to_89=false`

1. imwg_pd true
2. PD first-match even if other response flags are false
3. magent does not compute PD from serial values


## Also searched as

- IMWG response criteria
- Kumar 2016 myeloma response
- stringent complete response myeloma
- myeloma VGPR and PR
- International Myeloma Working Group response
- sCR CR VGPR PR
- IMWG M-protein response
- myeloma treatment response assessment

## Parameters

- `imwg_pd` (boolean, required): Progressive disease as assigned by the caller using IMWG PD rules (Kumar 2016). true or false. When true, response is PD regardless of CR or M-protein reduction flags. magent does not compute PD from serial M-protein, FLC, or imaging values.
- `ife_serum_negative` (boolean, required): Negative immunofixation on serum, as assigned by the caller (Kumar 2016 CR). true or false. magent does not perform immunofixation.
- `ife_urine_negative` (boolean, required): Negative immunofixation on urine, as assigned by the caller (Kumar 2016 CR). true or false. magent does not perform immunofixation.
- `plasmacytomas_absent` (boolean, required): Disappearance of soft-tissue plasmacytomas, as assigned by the caller (Kumar 2016 CR). true or false. magent does not read imaging or examine plasmacytomas.
- `bmpc_lt_5` (boolean, required): <5% plasma cells in bone marrow aspirates as assigned by the caller (Kumar 2016 CR; strictly fewer than 5%, not ≤5%). true or false. magent does not read a marrow.
- `flc_ratio_normal` (boolean, required): Normal serum free light-chain ratio as assigned by the caller (Kumar 2016 sCR). true or false. magent does not assay free light chains.
- `no_clonal_cells_ihc` (boolean, required): Absence of clonal cells in bone marrow biopsy by immunohistochemistry as assigned by the caller (Kumar 2016 sCR). true or false. magent does not read immunohistochemistry.
- `electrophoresis_negative` (boolean, required): Serum and urine M-protein detectable by immunofixation but not electrophoresis, as assigned by the caller (Kumar 2016 VGPR). true or false. magent does not perform electrophoresis.
- `serum_m_reduction_ge_90` (boolean, required): ≥90% reduction in serum M-protein from baseline as assigned by the caller (Kumar 2016 VGPR). true or false. magent does not assay M-protein.
- `urine_m_lt_100` (boolean, required): Urine M-protein <100 mg per 24 h as assigned by the caller (Kumar 2016 VGPR). true or false. magent does not assay urine M-protein.
- `serum_m_reduction_ge_50` (boolean, required): ≥50% reduction of serum M-protein from baseline as assigned by the caller (Kumar 2016 PR). true or false. magent does not assay M-protein.
- `urine_m_pr` (boolean, required): Reduction in 24 h urinary M-protein by ≥90% or to <200 mg per 24 h, as assigned by the caller as this one flag (Kumar 2016 PR). true or false. magent does not assay urine M-protein.
- `serum_m_reduction_25_to_49` (boolean, required): ≥25% but ≤49% reduction of serum M-protein from baseline as assigned by the caller (Kumar 2016 MR). true or false. magent does not assay M-protein.
- `urine_m_reduction_50_to_89` (boolean, required): 50–89% reduction of 24 h urine M-protein as assigned by the caller (Kumar 2016 MR). true or false. magent does not assay urine M-protein.

## Bulk (POST)

POST the same path with a JSON items array. The first item is the GET unit; each additional item is $0.002. Invalid items return HTTP 400 before settlement.

Method: `POST /api/calc/imwg_response`
Max items: 25
Price: unit_amount + extra_item_amount * (n - 1) (unit 5000 atomic, extra 2000 atomic)
Status: PREVIEW

- 1 to 25 items. Each item uses the same keys as the GET query parameters.
- POST of 1 item costs the same as GET. Lists longer than 25: chunk into multiple POSTs. Extra items still execute; do not pad dummy rows.
- The first invalid item fails the whole request (index in the 400 JSON). You are not charged.
- HTTP 200 is {count, path, items}. Each items[i] is the GET 200 body for that row.
- Catalog misses (empty matches, found=false) stay paid 200s inside that slot.
- x402 resource URL is this path plus n and body_sha256. Browsers that prefer text/html get the same paywall as GET; Pay retries POST with the same items.

Example request:

```json
{
  "items": [
    {
      "bmpc_lt_5": "true",
      "electrophoresis_negative": "false",
      "flc_ratio_normal": "true",
      "ife_serum_negative": "true",
      "ife_urine_negative": "true",
      "imwg_pd": "false",
      "no_clonal_cells_ihc": "true",
      "plasmacytomas_absent": "true",
      "serum_m_reduction_25_to_49": "false",
      "serum_m_reduction_ge_50": "false",
      "serum_m_reduction_ge_90": "false",
      "urine_m_lt_100": "false",
      "urine_m_pr": "false",
      "urine_m_reduction_50_to_89": "false"
    },
    {
      "bmpc_lt_5": "true",
      "electrophoresis_negative": "false",
      "flc_ratio_normal": "true",
      "ife_serum_negative": "true",
      "ife_urine_negative": "true",
      "imwg_pd": "false",
      "no_clonal_cells_ihc": "true",
      "plasmacytomas_absent": "true",
      "serum_m_reduction_25_to_49": "false",
      "serum_m_reduction_ge_50": "false",
      "serum_m_reduction_ge_90": "false",
      "urine_m_lt_100": "false",
      "urine_m_pr": "false",
      "urine_m_reduction_50_to_89": "false"
    }
  ]
}
```

Human paywall (two-item fixture): https://api.magentlab.com/paywall/bulk/imwg-response

Example 200:

```json
{
  "count": 2,
  "path": "/api/calc/imwg_response",
  "items": [
    {
      "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
      "citation": {
        "authors": "Kumar S, Paiva B, Anderson KC, Durie B, Landgren O, Moreau P, Munshi N, Lonial S, Bladé J, Mateos MV, Dimopoulos M, Kastritis E, Boccadoro M, Orlowski R, Zamagni E, Palumbo A, San Miguel J, Avet-Loiseau H, Goldschmidt H, van de Donk NWCJ, et al.",
        "doi": "10.1016/S1470-2045(16)30206-6",
        "id": "kumar-2016",
        "pmid": "27511158",
        "source": "Lancet Oncol. 2016;17(8):e328-e346",
        "title": "International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma"
      },
      "formula": "imwg_response",
      "formula_expression": "Kumar 2016 IMWG measurable serum+urine M-protein response, first-match: PD if imwg_pd; else sCR iff CR_bits and flc_ratio_normal and no_clonal_cells_ihc; else CR iff CR_bits; else VGPR iff electrophoresis_negative or (serum_m_reduction_ge_90 and urine_m_lt_100); else PR iff serum_m_reduction_ge_50 and urine_m_pr; else MR iff serum_m_reduction_25_to_49 and urine_m_reduction_50_to_89; else SD. CR_bits = ife_serum_negative and ife_urine_negative and plasmacytomas_absent and bmpc_lt_5 (strictly <5% marrow plasma cells). Not FLC-only or nonsecretory. Not MRD. Not a diagnosis",
      "criteria": [
        {
          "factor": "imwg_pd",
          "met": false
        },
        {
          "factor": "ife_serum_negative",
          "met": true
        },
        {
          "factor": "ife_urine_negative",
          "met": true
        },
        {
          "factor": "plasmacytomas_absent",
          "met": true
        },
        {
          "factor": "bmpc_lt_5",
          "met": true
        },
        {
          "factor": "cr_bits",
          "met": true
        },
        {
          "factor": "flc_ratio_normal",
          "met": true
        },
        {
          "factor": "no_clonal_cells_ihc",
          "met": true
        },
        {
          "factor": "electrophoresis_negative",
          "met": false
        },
        {
          "factor": "serum_m_reduction_ge_90",
          "met": false
        },
        {
          "factor": "urine_m_lt_100",
          "met": false
        },
        {
          "factor": "serum_m_reduction_ge_50",
          "met": false
        },
        {
          "factor": "urine_m_pr",
          "met": false
        },
        {
          "factor": "serum_m_reduction_25_to_49",
          "met": false
        },
        {
          "factor": "urine_m_reduction_50_to_89",
          "met": false
        }
      ],
      "cr_bits": true,
      "imwg_response": "sCR"
    },
    {
      "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
      "citation": {
        "authors": "Kumar S, Paiva B, Anderson KC, Durie B, Landgren O, Moreau P, Munshi N, Lonial S, Bladé J, Mateos MV, Dimopoulos M, Kastritis E, Boccadoro M, Orlowski R, Zamagni E, Palumbo A, San Miguel J, Avet-Loiseau H, Goldschmidt H, van de Donk NWCJ, et al.",
        "doi": "10.1016/S1470-2045(16)30206-6",
        "id": "kumar-2016",
        "pmid": "27511158",
        "source": "Lancet Oncol. 2016;17(8):e328-e346",
        "title": "International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma"
      },
      "formula": "imwg_response",
      "formula_expression": "Kumar 2016 IMWG measurable serum+urine M-protein response, first-match: PD if imwg_pd; else sCR iff CR_bits and flc_ratio_normal and no_clonal_cells_ihc; else CR iff CR_bits; else VGPR iff electrophoresis_negative or (serum_m_reduction_ge_90 and urine_m_lt_100); else PR iff serum_m_reduction_ge_50 and urine_m_pr; else MR iff serum_m_reduction_25_to_49 and urine_m_reduction_50_to_89; else SD. CR_bits = ife_serum_negative and ife_urine_negative and plasmacytomas_absent and bmpc_lt_5 (strictly <5% marrow plasma cells). Not FLC-only or nonsecretory. Not MRD. Not a diagnosis",
      "criteria": [
        {
          "factor": "imwg_pd",
          "met": false
        },
        {
          "factor": "ife_serum_negative",
          "met": true
        },
        {
          "factor": "ife_urine_negative",
          "met": true
        },
        {
          "factor": "plasmacytomas_absent",
          "met": true
        },
        {
          "factor": "bmpc_lt_5",
          "met": true
        },
        {
          "factor": "cr_bits",
          "met": true
        },
        {
          "factor": "flc_ratio_normal",
          "met": true
        },
        {
          "factor": "no_clonal_cells_ihc",
          "met": true
        },
        {
          "factor": "electrophoresis_negative",
          "met": false
        },
        {
          "factor": "serum_m_reduction_ge_90",
          "met": false
        },
        {
          "factor": "urine_m_lt_100",
          "met": false
        },
        {
          "factor": "serum_m_reduction_ge_50",
          "met": false
        },
        {
          "factor": "urine_m_pr",
          "met": false
        },
        {
          "factor": "serum_m_reduction_25_to_49",
          "met": false
        },
        {
          "factor": "urine_m_reduction_50_to_89",
          "met": false
        }
      ],
      "cr_bits": true,
      "imwg_response": "sCR"
    }
  ]
}
```

## Response fields

- `formula` (string): imwg_response
- `formula_expression` (string): Kumar 2016 IMWG measurable serum+urine M-protein first-match response rule
- `imwg_response` (string): sCR, CR, VGPR, PR, MR, SD, or PD. First-match on the measurable serum+urine M-protein pathway. Not a diagnosis. Not MRD.
- `cr_bits` (boolean): true iff ife_serum_negative, ife_urine_negative, plasmacytomas_absent, and bmpc_lt_5 are all true
- `criteria` (array): Per-factor Tree rows with factor and met for each caller flag and for cr_bits
- `citation` (object): Kumar 2016 Lancet Oncol IMWG response citation
- `disclaimer` (string): Not-a-device notice

## Example JSON

Frozen fixture. Not a live lookup.

```json
{
  "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
  "citation": {
    "authors": "Kumar S, Paiva B, Anderson KC, Durie B, Landgren O, Moreau P, Munshi N, Lonial S, Bladé J, Mateos MV, Dimopoulos M, Kastritis E, Boccadoro M, Orlowski R, Zamagni E, Palumbo A, San Miguel J, Avet-Loiseau H, Goldschmidt H, van de Donk NWCJ, et al.",
    "doi": "10.1016/S1470-2045(16)30206-6",
    "id": "kumar-2016",
    "pmid": "27511158",
    "source": "Lancet Oncol. 2016;17(8):e328-e346",
    "title": "International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma"
  },
  "formula": "imwg_response",
  "formula_expression": "Kumar 2016 IMWG measurable serum+urine M-protein response, first-match: PD if imwg_pd; else sCR iff CR_bits and flc_ratio_normal and no_clonal_cells_ihc; else CR iff CR_bits; else VGPR iff electrophoresis_negative or (serum_m_reduction_ge_90 and urine_m_lt_100); else PR iff serum_m_reduction_ge_50 and urine_m_pr; else MR iff serum_m_reduction_25_to_49 and urine_m_reduction_50_to_89; else SD. CR_bits = ife_serum_negative and ife_urine_negative and plasmacytomas_absent and bmpc_lt_5 (strictly <5% marrow plasma cells). Not FLC-only or nonsecretory. Not MRD. Not a diagnosis",
  "criteria": [
    {
      "factor": "imwg_pd",
      "met": false
    },
    {
      "factor": "ife_serum_negative",
      "met": true
    },
    {
      "factor": "ife_urine_negative",
      "met": true
    },
    {
      "factor": "plasmacytomas_absent",
      "met": true
    },
    {
      "factor": "bmpc_lt_5",
      "met": true
    },
    {
      "factor": "cr_bits",
      "met": true
    },
    {
      "factor": "flc_ratio_normal",
      "met": true
    },
    {
      "factor": "no_clonal_cells_ihc",
      "met": true
    },
    {
      "factor": "electrophoresis_negative",
      "met": false
    },
    {
      "factor": "serum_m_reduction_ge_90",
      "met": false
    },
    {
      "factor": "urine_m_lt_100",
      "met": false
    },
    {
      "factor": "serum_m_reduction_ge_50",
      "met": false
    },
    {
      "factor": "urine_m_pr",
      "met": false
    },
    {
      "factor": "serum_m_reduction_25_to_49",
      "met": false
    },
    {
      "factor": "urine_m_reduction_50_to_89",
      "met": false
    }
  ],
  "cr_bits": true,
  "imwg_response": "sCR"
}
```

## Errors

- HTTP 400 `invalid_flag`: boolean clinical flags must be true or false Returned before settlement; you are not charged.
- HTTP 400 `invalid_items`: POST body must be a JSON object with only an items array Returned before settlement; you are not charged.
- HTTP 400 `invalid_item_count`: items must be an array of 1 to 25 objects Returned before settlement; you are not charged.
- HTTP 400 `invalid_item`: each items entry must be a JSON object Returned before settlement; you are not charged.

Shared HTTP 402 and 503: https://magentlab.com/docs/payments

## Related tools

- [IMWG myeloma criteria](https://magentlab.com/docs/imwg-myeloma) — Apply the Rajkumar 2014 International Myeloma Working Group updated criteria for multiple myeloma requiring therapy: clonal bone marrow plasma cells ≥10% or biopsy-proven plasmacytoma plus at least one myeloma-defining event (CRAB or SLiM).
- [Myeloma ISS](https://magentlab.com/docs/myeloma-iss) — Apply the Greipp 2005 International Staging System for multiple myeloma from serum beta-2 microglobulin and albumin.

## Payment

Unpaid requests return HTTP 402 even if query parameters or POST items are missing or invalid, so CDP and agents can index the path. After a PAYMENT-SIGNATURE, invalid params return HTTP 400 JSON before settlement. magent does not charge. Fix the params, then request a new 402 quote for that complete URL. Catalog misses (empty matches, found=false) are valid paid 200s.

- GET the tool with Accept: application/json (do not send Accept: text/html unless you want the human paywall).
- HTTP 402 means you have not paid. Decode the base64 PAYMENT-REQUIRED header. HTTP 503 is not a new quote.
- Sign accepts[0] (exact, EIP-3009) with validBefore = now + maxTimeoutSeconds (600 seconds), or accepts[1] (batch-settlement deposit/voucher) on product GET. Ping and POST {items} stay exact. Magent retries transient facilitator 429/5xx before answering.
- Retry the same URL with PAYMENT-SIGNATURE (base64 JSON of accepted and payload). Magent attaches canonical extensions.bazaar on CDP verify/settle; echoing 402 bazaar is optional.
- Success is HTTP 200 JSON plus PAYMENT-RESPONSE. exact settles before the tool. batch-settlement verifies (and deposit-settles) before the tool and commits the charge after HTTP 2xx. HTTP 503: retry the same PAYMENT-SIGNATURE. Mint a new exact nonce only after a new HTTP 402.

- offered `exact` on eip155:8453: Fixed-price USDC on Base. The buyer authorizes the advertised amount (EIP-3009). magent settles before the tool runs (paymentFlow upfront). extra.assetTransferMethod=eip3009 extra.paymentFlow=upfront.
- offered `batch-settlement` on eip155:8453: Payment-channel vouchers claimed later in batches. Exact stays accepts[0]. Same-path POST {items} is still exact. extra.assetTransferMethod=eip3009 extra.paymentFlow=authorization.

- not offered `upto`: Not offered. Usage-based: buyer authorizes a ceiling, seller settles the actual amount after work. Reserved for a future metered tool. Not for current calculators or code search.

Same-path POST {items} is still scheme exact: one EIP-3009 authorization for GET unit plus $0.002 per extra item. That is not x402 batch-settlement (payment channels / vouchers).

Shared HTTP 402 and 503 table: https://magentlab.com/docs/payments

Stdio MCP (one process per host): https://magentlab.com/docs/mcp

## Guarantees

- HTTP 402 is unpaid, including a missing query. After PAYMENT-SIGNATURE, invalid parameters return HTTP 400 before settlement. You are not charged. HTTP 402 never includes the tool JSON.
- exact: settlement finishes before the tool (paymentFlow upfront). batch-settlement: verify/deposit before the tool; chargedCumulativeAmount commits after HTTP 2xx. Uncertain or failed settlement fails closed (HTTP 503). Retry the same PAYMENT-SIGNATURE.
- HTTP 402 is unpaid only. Do not sign a second authorization because of a 503.
- Execution is timeout-bounded and concurrency-capped.
- Calculator inputs are stored encrypted for allowlisted operators (Magent Console). They are not in public logs, SSH lookups, catalog, or rollups. Request logs store path without query.